National Institutes of Health Commissions PhysIQ to Develop COVID-19 Digital Biomarker

CHICAGO--(BUSINESS WIRE)-- #COVID19--The National Cancer Institute (NCI) and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the National Institutes of Health (NIH), have awarded physIQ a contract to develop an AI-based COVID-19 Decompensation Index (CDI) Digital Biomarker to address the rapid decline of high-risk COVID-19 patients. Today, high-risk COVID-19 patients and their providers are finding out too late that in the disease continuum they are getting sicker and need urgen